Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

f-star opens second research site in Cambridge, U.K.
April 2008
SHARING OPTIONS:

VIENNA, Austria—f-star, an antibody engineering company developing novel antibodies and antibody fragments based on its Modular Antibody Technology, recently announced that it will open a research facility in Cambridge, U.K. in addition to its headquarters here. The group located in Cambridge will mainly be responsible for lead generation as well as, in the future, for research related to the conduct of collaborative studies between f-star and its pharma and biotech partners. f-star's Cambridge site will start with a small group of highly experienced researchers in the field. The research group will be headed by Lutz Riechmann, a senior researcher with more than 20 years of experience in antibody research in Sir Gregory Winter's group at the Medical Research Council's Laboratory of Molecular Biology.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.